Bear Stearns initiates coverage on Keryx Biopharma (Nasdaq: KERX) with an 'outperform' rating and $18 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE